Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Huatan Zhike is a Traditional Chinese Medicine (TCM) proprietary granule formulation specifically developed for pediatric use. It is primarily indicated for the treatment of respiratory conditions in children, such as upper respiratory tract infections characterized by cough and excessive phlegm. The formulation is a complex herbal compound that has been studied for its antimicrobial properties and safety profile in pediatric patients. It is widely manufactured in China by various pharmaceutical companies, including Dalian Sky Chemical (DLSK), and is typically available in 5g or 9g bags for oral administration. The medicine is classified as a small molecule herbal preparation and is commonly utilized in clinical practice to facilitate the clearance of phlegm and suppress cough.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiao'er huatan zhike.